Serrapeptase Pregnancy !!better!! May 2026

No human trials or cohort studies exist. Evidence derives from: (1) in vitro studies showing serrapeptase degrades fibronectin and collagen—key to placental implantation; (2) animal data (rats, rabbits) indicating dose-dependent embryolethality and skeletal abnormalities at high doses; (3) theoretical risk of membrane rupture or placental abruption via fibrinogen depletion.

Clinical decision-making should prioritize manufacturer product inserts and local teratology services. This paper is for informational and educational purposes and does not constitute medical advice. Pregnant or nursing individuals should consult a physician before taking any enzyme supplement. serrapeptase pregnancy

Serrapeptase is contraindicated in pregnancy due to plausible mechanisms of harm (impaired implantation, hemorrhage, teratogenesis) and total absence of safety data. Avoidance is strongly advised, particularly in the first and third trimesters. No human trials or cohort studies exist